Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: FDPP–HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy
Pingping Lianga,
Jinjun Shaoa,
Qianyun Tanga,
Weili Si*a,
Qiang Wangc,
Qi Zhang*b and
Xiaochen Dong*a
aKey Laboratory of Flexible Electronics (KLOFE), Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing Tech University (NanjingTech), Nanjing, China. E-mail: iamxcdong@njtech.edu.cn
bSchool of Pharmaceutical Sciences, Nanjing Tech University (NanjingTech), Nanjing, China. E-mail: zhangqi@njtech.edu.cn
cCollege of Chemistry and Molecular Engineering, Nanjing Tech University (NanjingTech), Nanjing, China
First published on 12th June 2023
Abstract
Correction for ‘FDPP–HA as a theranostic agent for cancer-targeted fluorescence imaging and photodynamic therapy’ by Pingping Liang et al., RSC Adv., 2017, 7, 37369–37373, https://doi.org/10.1039/C7RA06551E.
In the original article in Fig. 6, incorrect H&E staining images were inserted for the control group (liver) and illumination group (spleen and kidney). The corrected versions are included below. The authors apologise for any inconvenience caused.
 | ||
| Fig. 6 Photographs of H&E staining for major organs including heart, liver, spleen, lung, and kidney obtained from three groups after 30 days of treatment. | ||
The results and conclusions of this paper are not affected by this correction.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |